Stanford University
Showing 401-500 of 1,332 Results
-
Kay Teel
Metadata Librarian for Serials and Arts Resources, Metadata Department
Current Role at StanfordI provide discovery metadata for serial publications in Western European languages in all formats and subject disciplines, and discovery metadata for monographic publications in Western European languages about the arts excluding music.
-
Kamran Tehranchi
Ph.D. Student in Civil and Environmental Engineering, admitted Autumn 2023
BioKamran Tehranchi is a Ph.D. Student in Civil & Environmental Engineering at Stanford University researching planning processes for decarbonized and reliable electricity systems. His work focuses on developing energy system optimization models to support policy analysis. He has previously worked in the public sector as a Shultz Energy Fellow at the California Independent System Operator (CAISO), an analyst at a Community Choice Aggregator (CCA), and within city and county governments. He is a member of the Interdisciplinary Energy Systems research group, advised by Professor Ines Azevedo. He holds a M.S. in Civil & Environmental Engineering from Stanford University and a B.S. in Mechanical Engineering at Northwestern University.
-
David Tehrani, MD, MS
Affiliate, Med/SHC Tri-Valley
BioDr. Tehrani is a board-certified, fellowship-trained interventional cardiologist with Stanford Health Care Tri-Valley in the East Bay.
He is focused on building long-term relationships with his patients and their families, while sharing his evidence-based expertise in the noninvasive and minimally invasive management of cardiovascular disease. He takes pride in forming care plans based on mutual decision-making.
Dr. Tehrani’s research interests include cutting-edge technology and advancements in medical management of cardiovascular disease. His clinical research studies and funded clinical research trials have focused on cardiovascular biomarkers, coronary physiology, cardiac hemodynamics, cardio-oncology, and procedural closure devices. His research background has been instrumental in helping him provide individualized, evidence-based care plans for conditions ranging from advanced heart failure to complex coronary disease.
Dr. Tehrani has an extensive clinical research background, with over 40 peer-reviewed publications in top cardiology journals. He has done over 30 presentations at conferences, including the American Heart Association (AHA) and American College of Cardiology (ACC) national meetings.
Dr. Tehrani is a member the American College of Cardiology, the American College of Physicians, the American Heart Association, the Heart Failure Society of America, and the International Society of Heart and Lung Transplantation. -
Merve Tekgürler
Ph.D. Student in History, admitted Autumn 2019
Masters Student in Symbolic Systems, admitted Autumn 2023BioMerve Tekgürler is a PhD candidate in History (ABD) and an M.S. student in Symbolic Systems. In AY 2023-24, they hold the inaugural Mellon/ACLS Dissertation Innovation Fellowship. Merve has a BA degree in History and Social and Cultural Anthropology from Freie University Berlin and an MA in History from Stanford.
Merve’s dissertation, tentatively titled “Crucible of Empire: Danubian Borderlands and the Making of Ottoman Administrative Mentalities” focuses on the Ottoman-Polish borderlands in the long 18th century (1760s-1820s), examining the changes and continuities north of the Danube River in relation to Russian and Austrian expansions. They study Ottoman news and information networks in this region and their impact on production and mobilisation of imperial knowledge.
As part of their dissertation project, Merve is training a handwritten text recognition model for 18th century Ottoman Turkish administrative hand and developing AI-based natural language processing tools for Ottoman Turkish. Their aim is to compile a large machine-readable corpus of manuscript news communiques and employ computational text analysis methods. In AY 2022-23, they were a Digital Humanities Graduate Fellow at Center for Spatial and Textual Analysis (CESTA) with their project on topic modeling in Ottoman court histories from the 18th and 19th centuries.
Merve’s research on the borderlands ties to their passion for maps and spatial humanities. They are the co-PI in Cistern: A Database of Geographical Knowledge in the Ottoman World, which they started with Adrien Zakar in Winter 2020. They also contributed to their advisor Ali Yaycıoğlu’s Mapping Ottoman Epirus project, building a placenames dataset from an Ottoman transportation map and developing a 3D model of the late-nineteenth century Ottoman Empire with exaggerated elevation data.
Previously, Merve was a G.J. Pigott Scholar (AY 2022-23) and graduate coordinator of Stanford Humanities Center Eurasian Empires Workshop (AY 2021-22 & 2022-23). They also worked as senior graduate mentor for the Undergraduate Research Internship at CESTA from Spring 2021 to Fall 2022. Outside academia, Merve enjoys playing tennis, doing gymnastics, and all kinds of DIY projects. -
Nicholas Telischak, MD, MS
Clinical Associate Professor, Radiology
Clinical Associate Professor (By courtesy), NeurosurgeryBioA native of the Bay Area, Dr. Nick Telischak is a dual fellowship-trained neurointerventional surgeon and neuroradiologist at Stanford Health Care. With board certifications in radiology and neuroradiology, he serves as a clinical associate professor in the Department of Radiology, and, by courtesy of the Department of Neurosurgery, at Stanford School of Medicine.
Dr. Telischak specializes in diagnosing and treating artery disorders in the brain and spine, including brain aneurysms, arteriovenous malformations (AVM), and dural arteriovenous fistula (dAVF), and stroke. Dr. Telischak also specializes in venous disorders in the brain including idiopathic intracranial hypertension (IIH). He also has a special interest in pulsatile tinnitus, a whooshing sound in the ears that occurs in rhythm with the heartbeat. Dr. Telischak also treats painful spinal (vertebral) fractures, spinal metastases (tumors resulting from cancer elsewhere in the body), and congenital vascular malformations (blood vessel abnormalities that are present at birth). He treats these conditions using minimally invasive, image-guided procedures and state-of-the-art technology.
Prior to joining Stanford Health Care, Dr. Telischak helped develop the Stroke Program at California Pacific Medical Center and Mills-Peninsula Medical Center, giving him a broad perspective on medical care systems within the Bay Area.
Dr. Telischak’s research focuses on:
• Identifying biomarkers to diagnose large vessel occlusion stroke (stroke in one of the large arteries in the brain)
• Noninvasive MRI techniques for diagnosing idiopathic intracranial hypertension (high pressure within the skull)
He is also the principal investigator for a study examining the efficacy of vertebroplasty and kyphoplasty for the treatment of painful vertebral compression fractures.
In addition, Dr. Telischak holds a master’s degree in bioengineering. He has worked with several companies pioneering new devices to treat brain aneurysms, vascular malformations, and strokes caused by blood clots, as well as new treatments for venous disorders in the brain caused by idiopathic intracranial hypertension.
Dr. Telischak has published more than 20 peer-reviewed articles and has been invited to present locally, nationally, and internationally at meetings for the Society of NeuroInterventional Surgery, American Society of Neuroradiology, and Jornada de Stroke in Asuncion, Paraguay, where he has served as visiting faculty. -
Melinda L. Telli, M.D.
Professor of Medicine (Oncology)
Current Research and Scholarly InterestsMy research focuses on the development of novel therapies for the treatment of triple-negative and hereditary cancer. Other areas of interest include prevention of cardiac damage associated with breast cancer treatment and cardiotoxicity of anti-cancer agents.
-
Kharis Templeman
Research Fellow, HOOVER RESEARCH
Current Research and Scholarly InterestsHis current research agenda includes work on China’s Taiwan policy, the drivers of defense spending in Taiwan, and Taiwan’s party system evolution after the transition to democracy.
-
Michael Temprano
Juris Doctor Student, Law
BioAs a 1L at Stanford Law School, I am excited to pursue high-stakes complex litigation. Before joining SLS, I worked as a paralegal at a trial law firm, where I drafted complaints, motions, demand letters, mediation/trial briefs, and liability memos. Though I initially joined the firm as part of the Pre-Litigation department, I eventually transitioned to the Litigation team. My experience across both departments equips me with an understanding of case development. Prior to my role as a paralegal, I interned at Bay Area Legal Aid, where I assisted over 1,000 pro se litigants with various civil legal matters. In recognition of my academic excellence and community service, the Cal Alumni Association honored me as a 2x Leadership Award recipient.
Extending my work ethic from the firm to the classroom, I graduated summa cum laude from UC Berkeley with a cumulative 4.00 GPA. Through UC Berkeley's Honors Sociology program, I wrote a socio-legal thesis titled "Litigating on the Public Radar: Class Action Accessibility & Transparency in California's Northern District." This thesis won the Departmental Citation, the highest honor awarded to one graduating senior for best undergraduate research and outstanding academic achievement. In addition to my coursework, I served as a Legal Research Fellow at Berkeley Law’s Civil Justice Research Initiative, where I briefed SCOTUS cases and analyzed settlement distribution in federal class actions. I also led as President of UC Berkeley’s Latine Pre-Law Society. In my free time, I volunteered at Legal Aid at Work, assisting pro se litigants with employment law matters. -
Joyce Teng, MD, PhD
Professor of Dermatology and, by courtesy, of Pediatrics
BioJoyce Teng, MD, PhD is a professor in dermatology at Stanford University. She is affiliated with multiple hospitals in the area, including Lucile Salter Packard Children's Hospital (LPCH) at Stanford and Stanford Hospital and Clinics (SHC). She received her medical degree from Vanderbilt University School of Medicine and has been in practice for more than 12 years. She is one of the 6 pediatric dermatologists practicing at LPCH and one of 72 at SHC who specialize in Dermatology. She sees patients with rare genetic disorders, birthmarks, vascular anomalies and a variety of inflammatory skin diseases. She is also an experienced pediatric dermatological surgeon. Her research interests are drug discovery and novel therapy for skin disorders.
-
Nelson Teng
Professor of Obstetrics and Gynecology (Oncology), Emeritus
Current Research and Scholarly InterestsGynecologic Malignancies
Immunotherapy
Biologic Response Modifiers
New Drug Development
Antigenic specificities of human antibodies encoded by the VH4-34 gene -
Valerie Teng
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioDr. Valerie Teng is a board certified family physician with special interests in preventative medicine and women's health. Her experiences in caring for patients with chronic conditions, such as diabetes and hypertension, have fueled her desire to partner with patients to enter healthier lifestyles. She is also passionate about providing comprehensive care to patients of all ages, including newborns and teens.
During her residency training, Dr. Teng explored many opportunities in medical education through the O’Connor-Stanford Leaders in Education Residency (OSLER) program. She is delighted to continue in medical education as a part of the faculty at Stanford Family Medicine. -
Azusa Terasaki
Postdoctoral Scholar, Pathology
BioAzusa Terasaki, MD, PhD, is a Postdoctoral scholar in the Department of Pathology at Stanford University School of Medicine. Her research focuses on tumor immunology and cancer metabolism, with a particular interest in mitochondrial transfer between cancer and immune cells and its role in immune suppression and metastasis.
Dr. Terasaki received her medical degree and PhD in Japan, where she completed her surgical training and is a board-certified surgeon with additional certifications as a breast specialist and in cancer therapy. During her clinical career, she developed a strong interest in translational research that bridges fundamental discoveries and patient care.
Her current work investigates how cancer cells reprogram immune cells through organelle transfer, integrating imaging, flow cytometry, and multi-omic approaches to uncover novel mechanisms of tumor–immune interaction. Her goal is to identify new therapeutic targets and biomarkers to improve cancer treatment outcomes. -
Nele Marie Terveen
Affiliate, Geballe Laboratory for Advanced Materials
BioNele Marie Terveen is an Assistant Professor (Lecturer) in Innovation & Strategy at the University of Auckland, New Zealand, and is affiliated with Stanford in Professor Yi Cui's lab.
In her research, she looks at complex problems, serendipity, and innovation as well as ideation processes, specifically in the sustainability domain. She loves to explore novel phenomena through inductive and ethnographic study designs.
She aims to drive transformation at the intersection of science and practice, was invited to speak in the European Parliament for the Green Pioneers, is involved as a Fellow in the Think Tank of the Club of Rome Germany, and serves as a jury member of the Green Startup Program of the Deutsche Bundesstiftung Umwelt, as well as an ambassador of the Economy for the Common Good. -
Stefano Testa, MD
Instructor, Medicine - Oncology
BioDr. Stefano Testa is a board-certified, fellowship-trained medical oncologist with Stanford Health Care. He is also a clinical instructor in the Department of Medicine, Division of Oncology at Stanford University School of Medicine.
Dr. Testa specializes in treating patients with sarcomas and other solid tumors using cellular therapy approaches. He has expertise in adoptive T-cell therapies, including chimeric antigen receptor T-cell (CAR-T) and T-cell receptor (TCR) therapies.
As a physician-scientist, Dr. Testa focuses on developing next-generation cellular therapies for solid tumors, particularly sarcomas. His research goal is to identify targets for adoptive T-cell therapies in solid tumors, including soft tissue and bone sarcomas, and on novel synthetic biology approaches to enhance the effectiveness of T-cell therapies against solid tumors.
Dr. Testa has authored numerous peer-reviewed publications in leading medical journals, including Immunity, Cancer Discovery, JAMA Network Open, Genome Medicine, and Biomacromolecules. He has presented his research at national and international scientific meetings, including the Connective Tissue Oncology Society Annual Meeting and the Society for Immunotherapy of Cancer Annual Meeting.
Dr. Testa is a member of the American Society of Clinical Oncology (ASCO), Connective Tissue Oncology Society (CTOS), the American Society of Hematology (ASH), and the Society for Immunotherapy of Cancer (SITC). -
Jeffrey Teuteberg
Professor of Medicine (Cardiovascular Medicine)
BioHe is currently a Professor of Medicine at Stanford, but is no longer seeing patients as he is on leave and working with industry.
His research interests are in clinical outcomes in patients after transplant and mechanical support as well as novel approaches to immunosuppression. He has participated in many single-center and multi-institutional research studies and has published widely in the fields of transplant and mechanical support. He served as President of the International Society of Heart and Lung Transplantation in 2018. -
Winifred Teuteberg
Clinical Professor, Medicine - Primary Care and Population Health
BioDr. Teuteberg completed residency training in Internal Medicine at the University of Chicago and a Palliative Medicine Fellowship at Massachusetts General Hospital. She joined the faculty at Stanford in 2017 and currently sees patients as a part of the inpatient palliative care consult team at Stanford Healthcare.
She has been the clinical director or Stanford Medicine's implementation of the Ariadne Labs' Serious Illness Care Program since its inception in 2018. Her interests include communication skills training, leveraging predictive algorithms to identify patients who would most benefit from serious illness conversations, how to empower non-physician clinical team members to participate in this work, and best practice for EHR builds related to advance care planning. -
Haluk Tezcan, MD
Adjunct Clinical Associate Professor, Medicine - Oncology
BioClinical focus:
Breast Oncology
Molecular Diagnostics
Dr. Tezcan is a medical oncologist and hematologist with over three decades of diverse experience in cancer management and research.
He is leading the clinical development of Droplet Biosciences' novel liquid biopsy technology, a first-in-class lymphatic fluid molecular residual disease assessment, overseeing the scientific and clinical development of the technology. With over three decades of direct patient care and clinical trial experience as a principal investigator and director, both in academia and private practice, he has a firsthand understanding of the unmet clinical needs of physicians and patients, as well as broad experience in clinical trial design and implementation.
He is also co-principal at Athea Oncology, guiding practices and hospitals in developing clinical trial programs and high-value real-world data collection and diagnostic companies in clinical development. He is also a reviewer of JCO Precision Medicine.
Before joining Athea Oncology and Droplet Biosciences, he was the co-founder of LexentBio, which was successfully acquired by Roche/FMI. He also served as Director of Translational Medicine at Genomic Health and as Vice President, leading oncology development at Counsyl, where he integrated science with clinical product development. He established the CA.RE.foundation, a cancer research foundation dedicated to enabling the execution of clinical trials across community oncology sites throughout the Northwest US. He has independently built multiple software tools to help oncologists navigate the practical realities of their daily work. -
Sonoo Thadaney Israni
Executive Director, Presence + Program in Bedside Medicine, Med/Program/Bedside Med
Current Role at StanfordExecutive Director, Presence (med.stanford.edu/presence.html) & Program in Bedside Medicine/Stanford 25 (stanfordmedicine25.stanford.edu)
Instructor Stanford University School of Medicine - Authentic Courage for Constructive Change: Skills and Practice for Leadership
LinkedIn Profile: www.linkedin.com/in/sonoo/ -
Julie Ngoc Thai, MD, MPH
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Thai is a fellowship-trained specialist in geriatric medicine. She provides care at the Stanford Senior Care Clinic.
She completed her fellowship training at the University of California, San Francisco. She is board-certified in family medicine through the American Board of Family Medicine .
Dr. Thai earned her medical degree from Michigan State University College of Human Medicine. She completed her residency in family medicine at McLaren Flint/Michigan State University College of Human Medicine where she served as chief resident.
She also holds a Master of Public Health degree from Columbia University.
Dr. Thai has a background in clinical and population health research. She recently received a grant from the Blue Cross Blue Shield of Michigan Foundation to study the role of motivational interviewing in smoking cessation.
She contributed to research in rheumatoid arthritis, lupus, and ankylosing spondylitis in the Division of Rheumatology, Department of Medicine at Cedars Sinai Medical Center.
Dr. Thai was also an endourology research fellow in the Department of Urology at Mount Sinai Health System. Research focused on renal stone disease, clinical markers and outcomes, and testing and development of new technologies.
She has co-authored articles on topics such as caregivers’ communication with elders living with late-life disability, palliative care practices in diverse settings, and the social consequences of forgetfulness and Alzheimer’s disease. These articles appeared in the American Journal of Hospice and Palliative Medicine, Journal of Palliative Medicine, Journal of Mental Health Aging, and other peer-reviewed journals
Dr. Thai is a member of the American Geriatrics Society, American Academy of Family Physicians, and California Academy of Family Physicians. She is also an inductee of the Alpha Omega Alpha Honor Medical Society.
She has volunteered with homeless shelters, women’s advocacy groups, Goodwill, the American Red Cross, and AmeriCorps.
Dr. Thai is fluent in English and proficient in speaking Vietnamese. -
Christoph Thaiss
Associate Professor of Pathology
Current Research and Scholarly InterestsThe Thaiss Lab investigates how gut-brain interactions influence health and disease. By studying microbiome-host communication, the lab explores how microbial signals impact immune function, metabolism, and neurological health. Using multi-omic technologies and computational models, they aim to uncover mechanisms underlying inflammation, neurological disorders, and metabolic diseases. Their research supports the development of personalized therapies targeting the gut-brain axis.
